Search

Search Constraints

You searched for: Author/Creator Messore, Barbara

Search Results

1. Ivacaftor improves lung disease in patients with advanced CF carrying CFTR mutations that confer residual function. (September 2020)

2. Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study. Issue 7 (July 2021)

3. The prognostic role of Gender‐Age‐Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone. (6th March 2019)

4. Treatment compliance in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection treated with tobramycin inhalation powder: The FREE study. (May 2018)